img

Global Aciclovir Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Aciclovir Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Aciclovir (ACV), also known as acyclovir, is an antiviral medication. It is primarily used for the treatment of herpes simplex virus infections, chickenpox, and shingles. Other uses include prevention of cytomegalovirus infections following transplant and severe complications of Epstein-Barr virus infection.
Aciclovir report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Aciclovir market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Drug Store are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Aciclovir industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Aciclovir key manufacturers include Greater Pharma, LBS Labs, GlaxoSmithKline, Lex Ano, Salutas, Novartis, Teva, Stada Nordic and Cimed Industria de Medicamentos, etc. Greater Pharma, LBS Labs, GlaxoSmithKline are top 3 players and held % sales share in total in 2022.
Aciclovir can be divided into Generic and Patent, etc. Generic is the mainstream product in the market, accounting for % sales share globally in 2022.
Aciclovir is widely used in various fields, such as Hospital and Drug Store, etc. Hospital provides greatest supports to the Aciclovir industry development. In 2022, global % sales of Aciclovir went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Aciclovir market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Greater Pharma
LBS Labs
GlaxoSmithKline
Lex Ano
Salutas
Novartis
Teva
Stada Nordic
Cimed Industria de Medicamentos
Reman Drug
L.E.T.I.
Nichi-Iko Pharmaceutical
Choseido Pharmaceutical
Shiono Kemikaru
Towa Yakuhin
Wockhardt
Takata Pharmaceutical
Aliud
Amneal Pharma
Apotex
Arrow
Laboratoires Servier
Sanofi
Mylan
Orion Pharma
Pfizer
Segment by Type
Generic
Patent

Segment by Application


Hospital
Drug Store

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Aciclovir market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Aciclovir, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Aciclovir industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Aciclovir in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Aciclovir introduction, etc. Aciclovir Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Aciclovir market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Aciclovir Market Overview
1.1 Aciclovir Product Overview
1.2 Aciclovir Market Segment by Type
1.2.1 Generic
1.2.2 Patent
1.3 Global Aciclovir Market Size by Type
1.3.1 Global Aciclovir Market Size Overview by Type (2024-2034)
1.3.2 Global Aciclovir Historic Market Size Review by Type (2024-2024)
1.3.3 Global Aciclovir Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Aciclovir Sales Breakdown by Type (2024-2024)
1.4.2 Europe Aciclovir Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Aciclovir Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Aciclovir Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Aciclovir Sales Breakdown by Type (2024-2024)
2 Global Aciclovir Market Competition by Company
2.1 Global Top Players by Aciclovir Sales (2024-2024)
2.2 Global Top Players by Aciclovir Revenue (2024-2024)
2.3 Global Top Players by Aciclovir Price (2024-2024)
2.4 Global Top Manufacturers Aciclovir Manufacturing Base Distribution, Sales Area, Product Type
2.5 Aciclovir Market Competitive Situation and Trends
2.5.1 Aciclovir Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Aciclovir Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Aciclovir as of 2022)
2.7 Date of Key Manufacturers Enter into Aciclovir Market
2.8 Key Manufacturers Aciclovir Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Aciclovir Status and Outlook by Region
3.1 Global Aciclovir Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Aciclovir Historic Market Size by Region
3.2.1 Global Aciclovir Sales in Volume by Region (2024-2024)
3.2.2 Global Aciclovir Sales in Value by Region (2024-2024)
3.2.3 Global Aciclovir Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Aciclovir Forecasted Market Size by Region
3.3.1 Global Aciclovir Sales in Volume by Region (2024-2034)
3.3.2 Global Aciclovir Sales in Value by Region (2024-2034)
3.3.3 Global Aciclovir Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Aciclovir by Application
4.1 Aciclovir Market Segment by Application
4.1.1 Hospital
4.1.2 Drug Store
4.2 Global Aciclovir Market Size by Application
4.2.1 Global Aciclovir Market Size Overview by Application (2024-2034)
4.2.2 Global Aciclovir Historic Market Size Review by Application (2024-2024)
4.2.3 Global Aciclovir Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Aciclovir Sales Breakdown by Application (2024-2024)
4.3.2 Europe Aciclovir Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Aciclovir Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Aciclovir Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Aciclovir Sales Breakdown by Application (2024-2024)
5 North America Aciclovir by Country
5.1 North America Aciclovir Historic Market Size by Country
5.1.1 North America Aciclovir Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Aciclovir Sales in Volume by Country (2024-2024)
5.1.3 North America Aciclovir Sales in Value by Country (2024-2024)
5.2 North America Aciclovir Forecasted Market Size by Country
5.2.1 North America Aciclovir Sales in Volume by Country (2024-2034)
5.2.2 North America Aciclovir Sales in Value by Country (2024-2034)
6 Europe Aciclovir by Country
6.1 Europe Aciclovir Historic Market Size by Country
6.1.1 Europe Aciclovir Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Aciclovir Sales in Volume by Country (2024-2024)
6.1.3 Europe Aciclovir Sales in Value by Country (2024-2024)
6.2 Europe Aciclovir Forecasted Market Size by Country
6.2.1 Europe Aciclovir Sales in Volume by Country (2024-2034)
6.2.2 Europe Aciclovir Sales in Value by Country (2024-2034)
7 Asia-Pacific Aciclovir by Region
7.1 Asia-Pacific Aciclovir Historic Market Size by Region
7.1.1 Asia-Pacific Aciclovir Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Aciclovir Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Aciclovir Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Aciclovir Forecasted Market Size by Region
7.2.1 Asia-Pacific Aciclovir Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Aciclovir Sales in Value by Region (2024-2034)
8 Latin America Aciclovir by Country
8.1 Latin America Aciclovir Historic Market Size by Country
8.1.1 Latin America Aciclovir Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Aciclovir Sales in Volume by Country (2024-2024)
8.1.3 Latin America Aciclovir Sales in Value by Country (2024-2024)
8.2 Latin America Aciclovir Forecasted Market Size by Country
8.2.1 Latin America Aciclovir Sales in Volume by Country (2024-2034)
8.2.2 Latin America Aciclovir Sales in Value by Country (2024-2034)
9 Middle East and Africa Aciclovir by Country
9.1 Middle East and Africa Aciclovir Historic Market Size by Country
9.1.1 Middle East and Africa Aciclovir Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Aciclovir Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Aciclovir Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Aciclovir Forecasted Market Size by Country
9.2.1 Middle East and Africa Aciclovir Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Aciclovir Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Greater Pharma
10.1.1 Greater Pharma Company Information
10.1.2 Greater Pharma Introduction and Business Overview
10.1.3 Greater Pharma Aciclovir Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Greater Pharma Aciclovir Products Offered
10.1.5 Greater Pharma Recent Development
10.2 LBS Labs
10.2.1 LBS Labs Company Information
10.2.2 LBS Labs Introduction and Business Overview
10.2.3 LBS Labs Aciclovir Sales, Revenue and Gross Margin (2024-2024)
10.2.4 LBS Labs Aciclovir Products Offered
10.2.5 LBS Labs Recent Development
10.3 GlaxoSmithKline
10.3.1 GlaxoSmithKline Company Information
10.3.2 GlaxoSmithKline Introduction and Business Overview
10.3.3 GlaxoSmithKline Aciclovir Sales, Revenue and Gross Margin (2024-2024)
10.3.4 GlaxoSmithKline Aciclovir Products Offered
10.3.5 GlaxoSmithKline Recent Development
10.4 Lex Ano
10.4.1 Lex Ano Company Information
10.4.2 Lex Ano Introduction and Business Overview
10.4.3 Lex Ano Aciclovir Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Lex Ano Aciclovir Products Offered
10.4.5 Lex Ano Recent Development
10.5 Salutas
10.5.1 Salutas Company Information
10.5.2 Salutas Introduction and Business Overview
10.5.3 Salutas Aciclovir Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Salutas Aciclovir Products Offered
10.5.5 Salutas Recent Development
10.6 Novartis
10.6.1 Novartis Company Information
10.6.2 Novartis Introduction and Business Overview
10.6.3 Novartis Aciclovir Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Novartis Aciclovir Products Offered
10.6.5 Novartis Recent Development
10.7 Teva
10.7.1 Teva Company Information
10.7.2 Teva Introduction and Business Overview
10.7.3 Teva Aciclovir Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Teva Aciclovir Products Offered
10.7.5 Teva Recent Development
10.8 Stada Nordic
10.8.1 Stada Nordic Company Information
10.8.2 Stada Nordic Introduction and Business Overview
10.8.3 Stada Nordic Aciclovir Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Stada Nordic Aciclovir Products Offered
10.8.5 Stada Nordic Recent Development
10.9 Cimed Industria de Medicamentos
10.9.1 Cimed Industria de Medicamentos Company Information
10.9.2 Cimed Industria de Medicamentos Introduction and Business Overview
10.9.3 Cimed Industria de Medicamentos Aciclovir Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Cimed Industria de Medicamentos Aciclovir Products Offered
10.9.5 Cimed Industria de Medicamentos Recent Development
10.10 Reman Drug
10.10.1 Reman Drug Company Information
10.10.2 Reman Drug Introduction and Business Overview
10.10.3 Reman Drug Aciclovir Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Reman Drug Aciclovir Products Offered
10.10.5 Reman Drug Recent Development
10.11 L.E.T.I.
10.11.1 L.E.T.I. Company Information
10.11.2 L.E.T.I. Introduction and Business Overview
10.11.3 L.E.T.I. Aciclovir Sales, Revenue and Gross Margin (2024-2024)
10.11.4 L.E.T.I. Aciclovir Products Offered
10.11.5 L.E.T.I. Recent Development
10.12 Nichi-Iko Pharmaceutical
10.12.1 Nichi-Iko Pharmaceutical Company Information
10.12.2 Nichi-Iko Pharmaceutical Introduction and Business Overview
10.12.3 Nichi-Iko Pharmaceutical Aciclovir Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Nichi-Iko Pharmaceutical Aciclovir Products Offered
10.12.5 Nichi-Iko Pharmaceutical Recent Development
10.13 Choseido Pharmaceutical
10.13.1 Choseido Pharmaceutical Company Information
10.13.2 Choseido Pharmaceutical Introduction and Business Overview
10.13.3 Choseido Pharmaceutical Aciclovir Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Choseido Pharmaceutical Aciclovir Products Offered
10.13.5 Choseido Pharmaceutical Recent Development
10.14 Shiono Kemikaru
10.14.1 Shiono Kemikaru Company Information
10.14.2 Shiono Kemikaru Introduction and Business Overview
10.14.3 Shiono Kemikaru Aciclovir Sales, Revenue and Gross Margin (2024-2024)
10.14.4 Shiono Kemikaru Aciclovir Products Offered
10.14.5 Shiono Kemikaru Recent Development
10.15 Towa Yakuhin
10.15.1 Towa Yakuhin Company Information
10.15.2 Towa Yakuhin Introduction and Business Overview
10.15.3 Towa Yakuhin Aciclovir Sales, Revenue and Gross Margin (2024-2024)
10.15.4 Towa Yakuhin Aciclovir Products Offered
10.15.5 Towa Yakuhin Recent Development
10.16 Wockhardt
10.16.1 Wockhardt Company Information
10.16.2 Wockhardt Introduction and Business Overview
10.16.3 Wockhardt Aciclovir Sales, Revenue and Gross Margin (2024-2024)
10.16.4 Wockhardt Aciclovir Products Offered
10.16.5 Wockhardt Recent Development
10.17 Takata Pharmaceutical
10.17.1 Takata Pharmaceutical Company Information
10.17.2 Takata Pharmaceutical Introduction and Business Overview
10.17.3 Takata Pharmaceutical Aciclovir Sales, Revenue and Gross Margin (2024-2024)
10.17.4 Takata Pharmaceutical Aciclovir Products Offered
10.17.5 Takata Pharmaceutical Recent Development
10.18 Aliud
10.18.1 Aliud Company Information
10.18.2 Aliud Introduction and Business Overview
10.18.3 Aliud Aciclovir Sales, Revenue and Gross Margin (2024-2024)
10.18.4 Aliud Aciclovir Products Offered
10.18.5 Aliud Recent Development
10.19 Amneal Pharma
10.19.1 Amneal Pharma Company Information
10.19.2 Amneal Pharma Introduction and Business Overview
10.19.3 Amneal Pharma Aciclovir Sales, Revenue and Gross Margin (2024-2024)
10.19.4 Amneal Pharma Aciclovir Products Offered
10.19.5 Amneal Pharma Recent Development
10.20 Apotex
10.20.1 Apotex Company Information
10.20.2 Apotex Introduction and Business Overview
10.20.3 Apotex Aciclovir Sales, Revenue and Gross Margin (2024-2024)
10.20.4 Apotex Aciclovir Products Offered
10.20.5 Apotex Recent Development
10.21 Arrow
10.21.1 Arrow Company Information
10.21.2 Arrow Introduction and Business Overview
10.21.3 Arrow Aciclovir Sales, Revenue and Gross Margin (2024-2024)
10.21.4 Arrow Aciclovir Products Offered
10.21.5 Arrow Recent Development
10.22 Laboratoires Servier
10.22.1 Laboratoires Servier Company Information
10.22.2 Laboratoires Servier Introduction and Business Overview
10.22.3 Laboratoires Servier Aciclovir Sales, Revenue and Gross Margin (2024-2024)
10.22.4 Laboratoires Servier Aciclovir Products Offered
10.22.5 Laboratoires Servier Recent Development
10.23 Sanofi
10.23.1 Sanofi Company Information
10.23.2 Sanofi Introduction and Business Overview
10.23.3 Sanofi Aciclovir Sales, Revenue and Gross Margin (2024-2024)
10.23.4 Sanofi Aciclovir Products Offered
10.23.5 Sanofi Recent Development
10.24 Mylan
10.24.1 Mylan Company Information
10.24.2 Mylan Introduction and Business Overview
10.24.3 Mylan Aciclovir Sales, Revenue and Gross Margin (2024-2024)
10.24.4 Mylan Aciclovir Products Offered
10.24.5 Mylan Recent Development
10.25 Orion Pharma
10.25.1 Orion Pharma Company Information
10.25.2 Orion Pharma Introduction and Business Overview
10.25.3 Orion Pharma Aciclovir Sales, Revenue and Gross Margin (2024-2024)
10.25.4 Orion Pharma Aciclovir Products Offered
10.25.5 Orion Pharma Recent Development
10.26 Pfizer
10.26.1 Pfizer Company Information
10.26.2 Pfizer Introduction and Business Overview
10.26.3 Pfizer Aciclovir Sales, Revenue and Gross Margin (2024-2024)
10.26.4 Pfizer Aciclovir Products Offered
10.26.5 Pfizer Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Aciclovir Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Aciclovir Industrial Chain Analysis
11.4 Aciclovir Market Dynamics
11.4.1 Aciclovir Industry Trends
11.4.2 Aciclovir Market Drivers
11.4.3 Aciclovir Market Challenges
11.4.4 Aciclovir Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Aciclovir Distributors
12.3 Aciclovir Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Generic
Table 2. Major Company of Patent
Table 3. Global Aciclovir Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Aciclovir Sales by Type (2024-2024) & (K Units)
Table 5. Global Aciclovir Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Aciclovir Sales by Type (2024-2024) & (US& Million)
Table 7. Global Aciclovir Market Share in Value by Type (2024-2024)
Table 8. Global Aciclovir Price by Type (2024-2024) & (US$/Unit)
Table 9. Global Aciclovir Sales by Type (2024-2034) & (K Units)
Table 10. Global Aciclovir Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Aciclovir Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Aciclovir Sales Market Share in Value by Type (2024-2034)
Table 13. Global Aciclovir Price by Type (2024-2034) & (US$/Unit)
Table 14. North America Aciclovir Sales by Type (2024-2024) & (K Units)
Table 15. North America Aciclovir Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Aciclovir Sales (K Units) by Type (2024-2024)
Table 17. Europe Aciclovir Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Aciclovir Sales (K Units) by Type (2024-2024)
Table 19. Asia-Pacific Aciclovir Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Aciclovir Sales (K Units) by Type (2024-2024)
Table 21. Latin America Aciclovir Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Aciclovir Sales (K Units) by Type (2024-2024)
Table 23. Middle East and Africa Aciclovir Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Aciclovir Sales by Company (2024-2024) & (K Units)
Table 25. Global Aciclovir Sales Share by Company (2024-2024)
Table 26. Global Aciclovir Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Aciclovir Revenue Share by Company (2024-2024)
Table 28. Global Market Aciclovir Price by Company (2024-2024) & (US$/Unit)
Table 29. Global Aciclovir Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Aciclovir Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Aciclovir as of 2022)
Table 32. Date of Key Manufacturers Enter into Aciclovir Market
Table 33. Key Manufacturers Aciclovir Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Aciclovir Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Aciclovir Sales by Region (2024-2024) & (K Units)
Table 37. Global Aciclovir Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Aciclovir Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Aciclovir Sales Market Share in Value by Region (2024-2024)
Table 40. Global Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 41. Global Aciclovir Sales by Region (2024-2034) & (K Units)
Table 42. Global Aciclovir Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Aciclovir Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Aciclovir Sales Market Share in Value by Region (2024-2034)
Table 45. Global Aciclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global Aciclovir Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Aciclovir Sales by Application (2024-2024) & (K Units)
Table 48. Global Aciclovir Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Aciclovir Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Aciclovir Sales Market Share in Value by Application (2024-2024)
Table 51. Global Aciclovir Price by Application (2024-2024) & (US$/Unit)
Table 52. Global Aciclovir Sales by Application (2024-2034) & (K Units)
Table 53. Global Aciclovir Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Aciclovir Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Aciclovir Sales Market Share in Value by Application (2024-2034)
Table 56. Global Aciclovir Price by Application (2024-2034) & (US$/Unit)
Table 57. North America Aciclovir Sales by Application (2024-2024) (K Units)
Table 58. North America Aciclovir Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Aciclovir Sales by Application (2024-2024) (K Units)
Table 60. Europe Aciclovir Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Aciclovir Sales by Application (2024-2024) (K Units)
Table 62. Asia-Pacific Aciclovir Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Aciclovir Sales by Application (2024-2024) (K Units)
Table 64. Latin America Aciclovir Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Aciclovir Sales by Application (2024-2024) (K Units)
Table 66. Middle East and Africa Aciclovir Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Aciclovir Sales by Country (2024-2024) & (K Units)
Table 68. North America Aciclovir Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Aciclovir Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Aciclovir Sales Market Share in Value by Country (2024-2024)
Table 71. North America Aciclovir Sales by Country (2024-2034) & (K Units)
Table 72. North America Aciclovir Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Aciclovir Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Aciclovir Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Aciclovir Sales by Country (2024-2024) & (K Units)
Table 76. Europe Aciclovir Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Aciclovir Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Aciclovir Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Aciclovir Sales by Country (2024-2034) & (K Units)
Table 80. Europe Aciclovir Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Aciclovir Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Aciclovir Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Aciclovir Sales by Region (2024-2024) & (K Units)
Table 84. Asia-Pacific Aciclovir Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Aciclovir Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Aciclovir Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Aciclovir Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Aciclovir Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Aciclovir Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Aciclovir Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Aciclovir Sales by Country (2024-2024) & (K Units)
Table 92. Latin America Aciclovir Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Aciclovir Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Aciclovir Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Aciclovir Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Aciclovir Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Aciclovir Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Aciclovir Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Aciclovir Sales by Country (2024-2024) & (K Units)
Table 100. Middle East and Africa Aciclovir Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Aciclovir Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Aciclovir Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Aciclovir Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Aciclovir Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Aciclovir Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Aciclovir Sales Market Share in Value by Country (2024-2034)
Table 107. Greater Pharma Company Information
Table 108. Greater Pharma Introduction and Business Overview
Table 109. Greater Pharma Aciclovir Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 110. Greater Pharma Aciclovir Product
Table 111. Greater Pharma Recent Development
Table 112. LBS Labs Company Information
Table 113. LBS Labs Introduction and Business Overview
Table 114. LBS Labs Aciclovir Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. LBS Labs Aciclovir Product
Table 116. LBS Labs Recent Development
Table 117. GlaxoSmithKline Company Information
Table 118. GlaxoSmithKline Introduction and Business Overview
Table 119. GlaxoSmithKline Aciclovir Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. GlaxoSmithKline Aciclovir Product
Table 121. GlaxoSmithKline Recent Development
Table 122. Lex Ano Company Information
Table 123. Lex Ano Introduction and Business Overview
Table 124. Lex Ano Aciclovir Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 125. Lex Ano Aciclovir Product
Table 126. Lex Ano Recent Development
Table 127. Salutas Company Information
Table 128. Salutas Introduction and Business Overview
Table 129. Salutas Aciclovir Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 130. Salutas Aciclovir Product
Table 131. Salutas Recent Development
Table 132. Novartis Company Information
Table 133. Novartis Introduction and Business Overview
Table 134. Novartis Aciclovir Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 135. Novartis Aciclovir Product
Table 136. Novartis Recent Development
Table 137. Teva Company Information
Table 138. Teva Introduction and Business Overview
Table 139. Teva Aciclovir Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 140. Teva Aciclovir Product
Table 141. Teva Recent Development
Table 142. Stada Nordic Company Information
Table 143. Stada Nordic Introduction and Business Overview
Table 144. Stada Nordic Aciclovir Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 145. Stada Nordic Aciclovir Product
Table 146. Stada Nordic Recent Development
Table 147. Cimed Industria de Medicamentos Company Information
Table 148. Cimed Industria de Medicamentos Introduction and Business Overview
Table 149. Cimed Industria de Medicamentos Aciclovir Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 150. Cimed Industria de Medicamentos Aciclovir Product
Table 151. Cimed Industria de Medicamentos Recent Development
Table 152. Reman Drug Company Information
Table 153. Reman Drug Introduction and Business Overview
Table 154. Reman Drug Aciclovir Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 155. Reman Drug Aciclovir Product
Table 156. Reman Drug Recent Development
Table 157. L.E.T.I. Company Information
Table 158. L.E.T.I. Introduction and Business Overview
Table 159. L.E.T.I. Aciclovir Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 160. L.E.T.I. Aciclovir Product
Table 161. L.E.T.I. Recent Development
Table 162. Nichi-Iko Pharmaceutical Company Information
Table 163. Nichi-Iko Pharmaceutical Introduction and Business Overview
Table 164. Nichi-Iko Pharmaceutical Aciclovir Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 165. Nichi-Iko Pharmaceutical Aciclovir Product
Table 166. Nichi-Iko Pharmaceutical Recent Development
Table 167. Choseido Pharmaceutical Company Information
Table 168. Choseido Pharmaceutical Introduction and Business Overview
Table 169. Choseido Pharmaceutical Aciclovir Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 170. Choseido Pharmaceutical Aciclovir Product
Table 171. Choseido Pharmaceutical Recent Development
Table 172. Shiono Kemikaru Company Information
Table 173. Shiono Kemikaru Introduction and Business Overview
Table 174. Shiono Kemikaru Aciclovir Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 175. Shiono Kemikaru Aciclovir Product
Table 176. Shiono Kemikaru Recent Development
Table 177. Towa Yakuhin Company Information
Table 178. Towa Yakuhin Introduction and Business Overview
Table 179. Towa Yakuhin Aciclovir Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 180. Towa Yakuhin Aciclovir Product
Table 181. Towa Yakuhin Recent Development
Table 182. Wockhardt Company Information
Table 183. Wockhardt Introduction and Business Overview
Table 184. Wockhardt Aciclovir Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 185. Wockhardt Aciclovir Product
Table 186. Wockhardt Recent Development
Table 187. Takata Pharmaceutical Company Information
Table 188. Takata Pharmaceutical Introduction and Business Overview
Table 189. Takata Pharmaceutical Aciclovir Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 190. Takata Pharmaceutical Aciclovir Product
Table 191. Takata Pharmaceutical Recent Development
Table 192. Aliud Company Information
Table 193. Aliud Introduction and Business Overview
Table 194. Aliud Aciclovir Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 195. Aliud Aciclovir Product
Table 196. Aliud Recent Development
Table 197. Amneal Pharma Company Information
Table 198. Amneal Pharma Introduction and Business Overview
Table 199. Amneal Pharma Aciclovir Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 200. Amneal Pharma Aciclovir Product
Table 201. Amneal Pharma Recent Development
Table 202. Apotex Company Information
Table 203. Apotex Introduction and Business Overview
Table 204. Apotex Aciclovir Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 205. Apotex Aciclovir Product
Table 206. Apotex Recent Development
Table 207. Arrow Company Information
Table 208. Arrow Introduction and Business Overview
Table 209. Arrow Aciclovir Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 210. Arrow Aciclovir Product
Table 211. Arrow Recent Development
Table 212. Laboratoires Servier Company Information
Table 213. Laboratoires Servier Introduction and Business Overview
Table 214. Laboratoires Servier Aciclovir Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 215. Laboratoires Servier Aciclovir Product
Table 216. Laboratoires Servier Recent Development
Table 217. Sanofi Company Information
Table 218. Sanofi Introduction and Business Overview
Table 219. Sanofi Aciclovir Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 220. Sanofi Aciclovir Product
Table 221. Sanofi Recent Development
Table 222. Mylan Company Information
Table 223. Mylan Introduction and Business Overview
Table 224. Mylan Aciclovir Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 225. Mylan Aciclovir Product
Table 226. Mylan Recent Development
Table 227. Orion Pharma Introduction and Business Overview
Table 228. Orion Pharma Aciclovir Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 229. Orion Pharma Aciclovir Product
Table 230. Orion Pharma Recent Development
Table 231. Orion Pharma Company Information
Table 232. Pfizer Company Information
Table 233. Pfizer Introduction and Business Overview
Table 234. Pfizer Aciclovir Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 235. Pfizer Aciclovir Product
Table 236. Pfizer Recent Development
Table 237. Key Raw Materials Lists
Table 238. Raw Materials Key Suppliers Lists
Table 239. Aciclovir Market Trends
Table 240. Aciclovir Market Drivers
Table 241. Aciclovir Market Challenges
Table 242. Aciclovir Market Restraints
Table 243. Aciclovir Distributors List
Table 244. Aciclovir Downstream Customers
Table 245. Research Programs/Design for This Report
Table 246. Key Data Information from Secondary Sources
Table 247. Key Data Information from Primary Sources
List of Figures
Figure 1. Aciclovir Product Picture
Figure 2. Global Aciclovir Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Aciclovir Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Aciclovir Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Generic
Figure 6. Global Generic Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Patent
Figure 8. Global Patent Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Global Aciclovir Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Aciclovir Sales Market Share by Type in 2022 & 2034
Figure 11. North America Aciclovir Sales Market Share in Volume by Type in 2022
Figure 12. North America Aciclovir Sales Market Share in Value by Type in 2022
Figure 13. Europe Aciclovir Sales Market Share in Volume by Type in 2022
Figure 14. Europe Aciclovir Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Aciclovir Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Aciclovir Sales Market Share in Value by Type in 2022
Figure 17. Latin America Aciclovir Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Aciclovir Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Aciclovir Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Aciclovir Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Aciclovir Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Aciclovir Revenue in 2022
Figure 23. Aciclovir Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Hospital
Figure 25. Global Hospital Sales YoY Growth (2024-2034) & (K Units)
Figure 26. Product Picture of Drug Store
Figure 27. Global Drug Store Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Global Aciclovir Sales by Application (2024-2034) & (US$ Million)
Figure 29. Global Aciclovir Sales Market Share by Application in 2022 & 2034
Figure 30. North America Aciclovir Sales Market Share in Volume by Application in 2022
Figure 31. North America Aciclovir Sales Market Share in Value by Application in 2022
Figure 32. Europe Aciclovir Sales Market Share in Volume by Application in 2022
Figure 33. Europe Aciclovir Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Aciclovir Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Aciclovir Sales Market Share in Value by Application in 2022
Figure 36. Latin America Aciclovir Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Aciclovir Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Aciclovir Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Aciclovir Manufacturing Cost Structure
Figure 41. Aciclovir Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed